Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02247349
Title BMS-986012 in Relapsed/Refractory SCLC
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0004 New York New York 10065 United States Details
Local Institution - 0001 Durham North Carolina 27710 United States Details
Local Institution - 0021 Winston-Salem North Carolina 27157 United States Details
Local Institution - 0020 St. Leonards New South Wales 2065 Australia Details
Local Institution - 0011 Brisbane Queensland 4102 Australia Details
Local Institution - 0002 Clayton Victoria 3168 Australia Details
Local Institution - 0015 Gent 9000 Belgium Details
Local Institution - 0012 Liege 4000 Belgium Details
Local Institution - 0003 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0017 Halifax Nova Scotia B3H 2Y9 Canada Details
Local Institution - 0019 Hamilton Ontario L8V 5C2 Canada Details
Local Institution - 0010 London Ontario N6A 4L6 Canada Details
Local Institution - 0007 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0008 Seoul 03080 Korea, Republic of Details
Local Institution - 0013 Nijmegen 6525 GA Netherlands Details
Local Institution - 0009 San Juan 00927 Puerto Rico Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field